Allana Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 3.09 Cr
as on 15-12-2024
- Paid Up Capital ₹ 3.00 Cr
as on 15-12-2024
- Company Age 40 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.65 Cr
as on 15-12-2024
- Revenue 1.64%
(FY 2019)
- Profit 8.22%
(FY 2019)
- Ebitda -77.70%
(FY 2019)
- Net Worth 2.68%
(FY 2019)
- Total Assets 2.67%
(FY 2019)
About Allana Pharmachem
The Corporate was formerly known as Allana Pharmachem Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.09 Cr and a paid-up capital of Rs 3.00 Cr.
The company has closed loans amounting to ₹5.65 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Aftab Alam and Prasad Kane serve as directors at the Company.
- CIN/LLPIN
U65990MH1984PTC032824
- Company No.
032824
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 May 1984
- Date of AGM
12 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Allana Pharmachem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aftab Alam  | Director | 30-Jun-2018 | Current |
| Prasad Kane | Director | 30-Jun-2018 | Current |
Financial Performance and Corporate Structure Insights of Allana Pharmachem.
Allana Pharmachem Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 1.64% increase. The company also saw a slight improvement in profitability, with a 8.22% increase in profit. The company's net worth moved up by a moderate rise of 2.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Allana Pharmachem?
In 2019, Allana Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 23 Jan 1996 | ₹2.85 Cr | Satisfied |
State Bank Of India Creation Date: 07 Mar 1989 | ₹1.00 Cr | Satisfied |
State Bank Of India Creation Date: 11 Feb 1989 | ₹1.80 Cr | Satisfied |
How Many Employees Work at Allana Pharmachem?
Unlock and access historical data on people associated with Allana Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Allana Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allana Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
